Agate Pass Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Agate Pass Investment Management's NVO Position: Q2 2026 in Review
Agate Pass Investment Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 7,984 shares — an estimated $293K sold.
Agate Pass Investment Management first reported a position in NVO in Q4 2021 and held it in 18 quarters. The position peaked at $1.89M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Agate Pass Investment Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Agate Pass Investment Management sold 7,984 Novo Nordisk shares in Q2 2026, an estimated $293K.
- Agate Pass Investment Management first reported a position in Novo Nordisk in Q4 2021 and held it in 18 quarters.
- Agate Pass Investment Management's Novo Nordisk position peaked at $1.89M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.